Clinical trial
Long-term Study Of Paroxetine in Women and Men
NCT00264654 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00264654 |
|---|---|
| Title | Long-term Study Of Paroxetine in Women and Men |
| Official title | Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Social Phobia/Social Anxiety Disorder (SAD) -A Open-Label, Uncontrolled, Long-term Study- <Phase III Study> |
| Acronym | SAD |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Social Phobia |
| Intervention type | Drug |
| Interventions | BRL29060A, paroxetine hydrochloride hydrate |
| Enrollment | 50 |
| Start date | Oct 1, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Dec 13, 2005 |
| Last update posted | Apr 15, 2013 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: